AXIM (AXIM Biotechnologies) Accounts Payable: $1.80 Mil (As of Jun. 2025)


What is AXIM Biotechnologies Accounts Payable?

AXIM Biotechnologies AXIM Accounts Payable is $1.80 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's Accounts Payable for the quarter that ended in Jun. 2025 was $1.80 Mil.

AXIM Biotechnologies's quarterly Accounts Payable increased from Dec. 2024 ($1.79 Mil) to Mar. 2025 ($1.93 Mil) but then declined from Mar. 2025 ($1.93 Mil) to Jun. 2025 ($1.80 Mil).

AXIM Biotechnologies's annual Accounts Payable increased from Dec. 2022 ($1.32 Mil) to Dec. 2023 ($2.78 Mil) but then declined from Dec. 2023 ($2.78 Mil) to Dec. 2024 ($1.79 Mil).

AXIM Biotechnologies Accounts Payable Related Terms

AXIM Biotechnologies Accounts Payable Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Accounts Payable Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 0.91 1.32 2.78 1.79

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.63 1.67 1.79 1.93 1.80

AXIM Biotechnologies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.80 Mil mean?
AXIM Biotechnologies (AXIM) has a Accounts Payable of $1.80 Mil as of Jun. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on AXIM Biotechnologies and its competitors.
Is AXIM Biotechnologies' Accounts Payable too high?
AXIM Biotechnologies' current Accounts Payable is $1.80 Mil.
How does AXIM Biotechnologies' Accounts Payable compare to HEPA and SCNI?
AXIM Biotechnologies' Accounts Payable of $1.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Accounts Payable is $1.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Accounts Payable of $1.80 Mil. The current Accounts Payable is $1.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Accounts Payable is $1.80 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.